| Title | Description | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Active Ingredients |
|
||||||||||||||||||||||||||||||||||||||||
| Dosage Form | LIQUID | ||||||||||||||||||||||||||||||||||||||||
| Packaging | 59 mL in 1 BOTTLE, DROPPER (64616-086-02), | ||||||||||||||||||||||||||||||||||||||||
| Pharm Type | Acidifying Activity [MoA], Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Anti-coagulant [EPC], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Coagulation Factor Activity [PE], Inhibit Ovum Fertilization [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |